Publication | Closed Access

Fine tuning of 4,6-bisphenyl-2-(3-alkoxyanilino)pyrimidine focusing on the activity-sensitive aminoalkoxy moiety for a therapeutically useful inhibitor of receptor for advanced glycation end products (RAGE)

Medicinal ChemistryBiochemistryFunctional SelectivityMedicineNatural SciencesMechanism Of ActionPharmacological AgentActivity-sensitive Aminoalkoxy MoietyPharmacotherapyFine TuningUseful InhibitorPharmacologyDrug Discovery